Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches

NCT00172094 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Headache

Interventions

DRUG: NPS 1776 (800 mg)
DRUG: PLACEBO
DRUG: NPS 1776 (400 mg)

Sponsor

Shire